Benjamin Jackson Sera Prognostics, Inc. (SERA) insider trading activity

Benjamin Jackson is General Counsel of SERA PROGNOSTICS, INC.. Currently has a direct ownership of 127,751 shares of SERA, which is worth approximately $388,363. The most recent transaction as insider was on Aug 08, 2025, when has been sold 6,447 shares (Class A Common Stock) at a price of $2.54 per share, resulting in proceeds of $16,375. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 128K

5.48% 3M change

8.92% 12M change

Total Value Held $388,363

Benjamin Jackson Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 08 2025	SELL Open market or private sale	$16,375 $2.54 p/Share	6,447 Reduced 4.8%	127,751 Class A Common Stock
Jun 10 2025	SELL Open market or private sale	$1,428 $1.48 p/Share	965 Reduced 0.71%	134,198 Class A Common Stock
May 30 2025	BUY Grant, award, or other acquisition	$4,924 $1.33 p/Share	3,703 Added 2.67%	135,163 Class A Common Stock
May 08 2025	SELL Open market or private sale	$17,284 $2.44 p/Share	7,084 Reduced 5.11%	131,460 Class A Common Stock
Mar 06 2025	SELL Open market or private sale	$9,505 $4.16 p/Share	2,285 Reduced 1.62%	138,544 Class A Common Stock
Mar 05 2025	BUY Grant, award, or other acquisition	-	34,590 Added 19.72%	140,829 Class A Common Stock
Feb 13 2025	SELL Open market or private sale	$27,090 $4.58 p/Share	5,915 Reduced 5.27%	106,239 Class A Common Stock
Jan 14 2025	SELL Open market or private sale	$52,123 $6.2 p/Share	8,407 Reduced 6.97%	112,154 Class A Common Stock
Jan 13 2025	SELL Open market or private sale	$50,478 $6.38 p/Share	7,912 Reduced 6.16%	120,561 Class A Common Stock
Jan 10 2025	SELL Open market or private sale	$102,327 $7.71 p/Share	13,272 Reduced 9.36%	128,473 Class A Common Stock
Nov 11 2024	SELL Open market or private sale	$34,601 $7.32 p/Share	4,727 Reduced 3.37%	135,528 Class A Common Stock
Aug 07 2024	SELL Open market or private sale	$37,263 $7.42 p/Share	5,022 Reduced 3.46%	140,255 Class A Common Stock
May 08 2024	SELL Open market or private sale	$47,010 $9.59 p/Share	4,902 Reduced 3.26%	145,277 Class A Common Stock
Mar 06 2024	SELL Open market or private sale	$16,741 $9.02 p/Share	1,856 Reduced 1.22%	150,179 Class A Common Stock
Feb 06 2024	SELL Open market or private sale	$45,489 $8.03 p/Share	5,665 Reduced 3.59%	152,035 Class A Common Stock
Dec 07 2023	SELL Open market or private sale	$52,200 $5.22 p/Share	10,000 Reduced 5.96%	157,700 Class A Common Stock
Nov 06 2023	BUY Grant, award, or other acquisition	-	125,000 Added 43.45%	162,700 Class A Common Stock
Mar 06 2023	BUY Grant, award, or other acquisition	-	24,700 Added 43.03%	32,700 Class A Common Stock
Jun 14 2022	BUY Open market or private purchase	$9,600 $1.2 p/Share	8,000 Added 50.0%	8,000 Class A Common Stock

Also insider at

MYGN

MYRIAD GENETICS INC Healthcare

E.V.P., General Counsel